Soleno Therapeutics Inc [NASDAQ: SLNO] price surged by 9.11 percent to reach at $4.34.
The one-year SLNO stock forecast points to a potential upside of 27.94. The average equity rating for SLNO stock is currently 1.12, trading closer to a bullish pattern in the stock market.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Guru’s Opinion on Soleno Therapeutics Inc [SLNO]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for SLNO shares is $72.12 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on SLNO stock is a recommendation set at 1.12. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
H.C. Wainwright have made an estimate for Soleno Therapeutics Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on September 03, 2024. While these analysts kept the previous recommendation, Robert W. Baird raised their target price to Outperform. The new note on the price target was released on May 10, 2024, representing the official price target for Soleno Therapeutics Inc stock. Previously, the target price had yet another raise to $93, while Piper Sandler analysts kept a Overweight rating on SLNO stock.
The Average True Range (ATR) for Soleno Therapeutics Inc is set at 2.79 The Price to Book ratio for the last quarter was 7.11, with the Price to Cash per share for the same quarter was set at 6.85.
SLNO Stock Performance Analysis:
Soleno Therapeutics Inc [SLNO] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 4.71. With this latest performance, SLNO shares gained by 6.61% in over the last four-week period, additionally plugging by 26.48% over the last 6 months – not to mention a rise of 123.24% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for SLNO stock in for the last two-week period is set at 56.79, with the RSI for the last a single of trading hit 59.81, and the three-weeks RSI is set at 55.37 for Soleno Therapeutics Inc [SLNO]. The present Moving Average for the last 50 days of trading for this stock 48.95, while it was recorded at 49.57 for the last single week of trading, and 45.12 for the last 200 days.
Insight into Soleno Therapeutics Inc Fundamentals:
Soleno Therapeutics Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 29.24 and a Current Ratio set at 29.24.
SLNO Stock EPS
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for SLNO. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Soleno Therapeutics Inc go to 15.00%.
Soleno Therapeutics Inc [SLNO] Institutonal Ownership Details
There are presently around $109.51%, or 113.32%% of SLNO stock, in the hands of institutional investors. The top three institutional holders of SLNO stocks are: VIVO CAPITAL, LLC with ownership of 7.32 million shares, which is approximately 20.2076%. CARLYLE GROUP INC., holding 4.07 million shares of the stock with an approximate value of $$166.36 million in SLNO stocks shares; and CARLYLE GROUP INC., currently with $$137.14 million in SLNO stock with ownership which is approximately 9.2765%.
